1-4 of 4
Sylvia Takacova
Close
Sort by
Journal Articles

Analysis of Clonal Evolution in Chronic Lymphocytic Leukemia from Inactive to Symptomatic Disease Prior Treatment Using Whole-Exome Sequencing

María Hernández-Sánchez, Lenka Radova, PhD, Jana Kotaskova, David Tamborero, PhD, Ana E Rodriguez, PhD, Karla Plevova, PhD, María Abáigar, PhD, Vasileios Bikos, Rocío Benito, PhD, Sylvia Takacova, PhD, Miguel Quijada, Ana África Martín, MD, Miguel Alcoceba, BSc, PhD, Alfonso García de Coca, Michael Doubek, Marcos González, MD PhD, Nuria Lopez-Bigas, PhD, Sarka Pospisilova, Jesús María Hernández-Rivas, MD
Journal: Blood
Blood (2016) 128 (22): 3206.
https://doi.org/10.1182/blood.V128.22.3206.3206
Published: 2016
Journal Articles

The Potential Role of the Six1/Eya1 Pathway in the Establishment of Leukemia Stem Cells in MLL-ENL – Induced Leukemia

Sylvia Takacova, PhD, Pavla Luzna, MSc, Viktor Stranecky, MSc, Vladimir Divoky
Journal: Blood
Blood (2011) 118 (21): 1362.
https://doi.org/10.1182/blood.V118.21.1362.1362
Published: 2011
Journal Articles

DNA Damage Response Is a Barrier in the Mixed Lineage Leukemia Development.

Sylvia Takacova, PhD, Jiri Zavadil, PhD, MSC, Jiri Bartek, MD, PhD, Vladimir Divoky, PhD
Journal: Blood
Blood (2009) 114 (22): 2399.
https://doi.org/10.1182/blood.V114.22.2399.2399
Published: 2009
Journal Articles

Evidence for An Anti-Cancer Barrier in a Mixed Lineage Leukemia Mouse Model in Vivo .

Sylvia Takacova, Jiri Bartek, Lucie Piterkova, Robert K. Slany, Vladimir Divoky
Journal: Blood
Blood (2008) 112 (11): 3347.
https://doi.org/10.1182/blood.V112.11.3347.3347
Published: 2008